Association between annual household income and adverse outcomes in patients who had ischaemic stroke

Yuhan Zang1, Zhengbao Zhu1, Mengyao Shi2

  • 1Department of Epidemiology, Soochow University Medical College, Suzhou, Jiangsu, China.

Insights

Low annual household income increases the risk of poor outcomes after ischemic stroke. This study found a significant association between lower income levels and adverse clinical events within three months post-stroke.

Area of Science:

  • Neurology
  • Public Health
  • Socioeconomics

Background:

  • The relationship between socioeconomic status and health outcomes, specifically ischemic stroke prognosis, requires further investigation.
  • Previous studies have yielded debatable results regarding the association between annual household income and stroke outcomes.

Purpose of the Study:

  • To prospectively examine the association between annual household income and prognosis at 3 months following ischemic stroke.
  • To investigate if lower income levels correlate with poorer outcomes after an ischemic stroke.

Main Methods:

  • A prospective study included 3975 participants from the China Antihypertensive Trial in Acute Ischemic Stroke.
  • Participants were stratified into three income groups: <¥10,000, ¥10,000-19,999, and ≥¥20,000 RMB.
  • A meta-analysis combined current findings with previous studies to assess the income-outcome association.

Main Results:

  • 1002 participants (25.20%) experienced the primary composite outcome of death or major disability within 3 months.
  • After adjustment, low annual household income was linked to a higher risk of the primary outcome (OR 1.60; P=0.034).
  • Meta-analysis confirmed a significant association between lower income levels and increased risk of death or major disability post-stroke (pooled RR 1.31).

Conclusions:

  • Low annual household income per capita is significantly associated with increased risks of adverse clinical outcomes at 3 months post-ischemic stroke.
  • This association appears independent of established stroke risk factors.
  • Further research is needed to validate these findings in diverse populations, considering potential limitations like patient exclusion criteria.
Abstract

Related Concept Videos

Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
99
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.0K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
88
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
70
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
513
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
1.9K